Abstract:Background: 45% of Liver grafts from donation after cardiac death (DCD) are discarded for transplantation because of their poor tolerance to ischemia reperfusion injury (IRI). Based on the previous research, tetramethylpyrazine(TMP) could reduce liver IRI of DCD in rats model, but the molecular mechanisms are unclear. Objective: This work aims to investigate the molecular mechanisms, it would to provide effective ideas for clinical evaluation and repair of DCD liver. Methods: The DCD model was established by cardiac arrest caused by asphyxia. The rat liver was induced 30min of in-situ warm ischemia and then to be placed in 4℃ UW solution for 3h,followed by 1h hypothermic oxygenated machine perfusion (HOPE). TMP (50mg/kg) was injected by dorsal vein of the penis in rats for 1h before DCD. PPARγ agonist Rosiglitazone and inhibitor GW9662 were administered 30min before DCD modeling, respectively.The liver of DCD of each group received orthotopic liver transplantation. Blood and tissue samples were collected 6h after the operation. The levels of ALT and AST in serum were detected by automatic biochemical analyzer, the levels of IL-1β and TNF-a in serum were detected by ELISA, and the morphological changes of liver were observed by HE staining. The protein expressions of PPARγ, NRF2, KEAP1, NQO1 and HO-1 were detected by Western bolting, and the mRNA levels of TLR-4, TRIF and MYD88 were detected by PCR. The postoperative survival rate was evaluated. Results: Serum ALT and AST levels in HOPE group were 4094±778.156 U/L and 6869.6±1324.486 U/L, respectively, 6 hours after liver transplantation. Serum ALT and AST in Rosiglitazone group were 3783.2±851.737U/L and 4773.6±1105.611 U/L, respectively, without statistical significance (P =0.632, P =0.016). The ALT and AST of PPARγ inhibitor GW9662 group were 8638.2±1886.557 U/L and 8321±2099.721U/L, respectively (P <0.01). The serum levels of IL-6 and TNF-a in Rosiglitazone group were significantly lower than those in PPARγ inhibitor GW9662 group (P <0.05). The expressions of PPARγ, NRF2, KEAP1, NQO1 and HO-1 in DCD liver were found to be the lowest in GW9662 group (P <0.05). Therefore, we inferred that HOPE can enhance the ability of TMP to activate PPARγ, and then to stimulate the expression of Nrf2 to induce transcription and activation of downstream.The expression of TLR-4 and TRIF decreased in the Rosiglitazone group (P <0.05), while the expression of MYD88 did not change significantly, suggesting that the enhanced anti-immune response of HOPE may be related to the activation of PPARγ by TMP and the inhibition of TLR-4/TRIF pathway. Compared with the 1-week survival rate, the survival rate of the normal liver group was 100% (6/6), the survival rate of the CS and HOPE groups was 50% (3/6) and 83% (5/6), respectively. The main causes of death within 24 hours were pulmonary embolism and postoperative hypothermia, and the main cause of death within 7 days was biliary complications. Conclusion: HOPE enhanced the protective effect of TMP on improving the quality of DCD donor-derived liver transplantation, and its repair mechanism may be related to NRF2/PPARγ and TLR-4/TRIF signals, providing a new trail for DCD donor-derived liver. Key words：liver transplantation; hypothermic oxygenated machine perfusion; donation after cardiac death; tetramethylpyrazine; PPARγ; NRF2. Science and Technology Innovation Cultivation Fund of Zhongnan Hospital of Wuhan University(No.znpy2019041). National Natural Science Foundation of China (Grant No. 81970548). Medical Science Advancement Program (Youth Scholars) of Wuhan University (Grant No. TFZZ2018035).

Hypothermic Machine Perfusion Attenuates Ischemia/reperfusion Injury Against Rat Livers Donated after Cardiac Death by Activating the Keap1/Nrf2‑ARE Signaling Pathway.

Hypothermic Machine Perfusion Ameliorates Inflammation During Ischemia-Reperfusion Injury Via Sirtuin-1-mediated Deacetylation of Nuclear Factor-Κb P65 in Rat Livers Donated after Circulatory Death

Appropriate Timing for Hypothermic Machine Perfusion to Preserve Livers Donated after Circulatory Death

Protective effect of hypothermic machine perfusion in the rat from donor after cardiac death liver transplantation

Hypothermic Machine Perfusion(HMP) attenuates liver inflammation response after reperfusion through upregulating expression of KLF2

Hypothermic Oxygenated Machine Perfusion Alleviates Liver Injury in Donation after Circulatory Death Through Activating Autophagy in Mice

Normothermic Machine Perfusion Combined with Bone Marrow Mesenchymal Stem Cells Improves the Oxidative Stress Response and Mitochondrial Function in Rat Donation After Circulatory Death Livers

411.5: Autophagy Mediates Liver Functional Recovery From Donation After Circulatory Death Rats With Normothermic Machine Perfusion

P2.08: Evaluation and Maintenance of Donor Liver Quality in Rats From Donated After Cardiac Death by Hypothermic Oxygenated Machine Perfusion and Cold Storage

Combined Liver‐kidney Perfusion Enhances Protective Effects of Normothermic Perfusion on Liver Grafts from Donation after Cardiac Death

Cytochrome P450 2E1 Predicts Liver Functional Recovery from Donation after Circulatory Death Using Air-Ventilated Normothermic Machine Perfusion

KEAP1-NRF2 Complex in Ischemia-Induced Hepatocellular Damage of Mouse Liver Transplants

Hypothermic Machine Perfusion Decreases Renal Cell Apoptosis During Ischemia/Reperfusion Injury Via the Ezrin/AKT Pathway

Donor Treatment With a Hypoxia-Inducible Factor-1 Agonist Prevents Donation After Cardiac Death Liver Graft Injury in a Rat Isolated Perfusion Model.

Mechanisms of Hypothermic Machine Perfusion to Decrease Donation after Cardiac Death Graft Inflammation: Through the Pathway of Upregulating Expression of KLF2 and Inhibiting TGF-β Signaling.

Hypothermic Oxygenated Machine Perfusion Promotes Mitophagy Flux against Hypoxia-Ischemic Injury in Rat DCD Liver

Effects of SP600125 and hypothermic machine perfusion on livers donated after cardiac death in a pig allograft transplantation model

Hypothermic Oxygenated Perfusion (HOPE) Attenuates Ischemia/reperfusion Injury in the Liver Through Inhibition of the TXNIP/NLRP3 Inflammasome Pathway in a Rat Model of Donation after Cardiac Death

A Novel Hypothermic Machine Perfusion System Using a LifePort Kidney Transporter for the Preservation of Rat Liver

212.4: Tetramethylpyrazine Alleviates Liver Ischemia-reperfusion Injury of Transplantation in Rat Model From Donation After Cardiac Death via Activation of PPARγ/Nrf2 Signaling Pathway

Hypothermic Machine Perfusion Reduced Inflammatory Reaction by Downregulating the Expression of Matrix Metalloproteinase 9 in a Reperfusion Model of Donation After Cardiac Death.